Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease-Reference-Cited by-同舟云学术

Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease

Published:2012-07 Issue: Volume:53 Page:13-21
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Pawar Sachin A.,Jabgunde Amit M.,Govender Patrick,Maguire Glenn E.M.,Kruger Hendrik G.,Parboosing Raveen,Soliman Mahmoud E.S.,Sayed Yasien,Dhavale Dilip D.,Govender Thavendran

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference43 articles.

1. What to call the AIDS virus;Coffin;Nature,1986

2. Comparative studies on inhibitors of HIV protease: a target for drug design;Jayaraman;In Silico Biology,2008

3. Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligands;Ghosh;Bioorganic & Medicinal Chemistry Letters,2010

4. Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases;Wei;Bioorganic & Medicinal Chemistry,2009

5. Design and synthesis of a protein:Farnesyltransferase inhibitor based on sugar amino acids;Overkleeft;Tetrahedron Letters,1999

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoconjugates of Mucochloric Acid—Synthesis and Biological Activity;Pharmaceuticals;2023-03-31

2. Improved Production of HIV-1 Subtype C Protease from Transgenic E. Coli;The Open Microbiology Journal;2021-12-31

3. From Recognition to Reaction Mechanism: An Overview on the Interactions between HIV-1 Protease and its Natural Targets;Current Medicinal Chemistry;2020-06-02

4. Recent trends and challenges on carbohydrate-based molecular scaffolding: general consideration toward impact of carbohydrates in drug discovery and development;Carbohydrates in Drug Discovery and Development;2020

5. An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant;Journal of Computer-Aided Molecular Design;2018-02-03